The genetic factors that play a role in late-stage liver disease remain controversial, although several studies have shown that variants in MICA, DEPDC5, HCP5 and PNPLA3 affect HCC development6–8,17. This evidence concerns the gene HCP5 and hepatocellular carcinoma.